469 related articles for article (PubMed ID: 11033346)
1. Regulation of APP cleavage by alpha-, beta- and gamma-secretases.
Nunan J; Small DH
FEBS Lett; 2000 Oct; 483(1):6-10. PubMed ID: 11033346
[TBL] [Abstract][Full Text] [Related]
2. Amyloid precursor protein compartmentalization restricts beta-amyloid production: therapeutic targets based on BACE compartmentalization.
Gandhi S; Refolo LM; Sambamurti K
J Mol Neurosci; 2004; 24(1):137-43. PubMed ID: 15314262
[TBL] [Abstract][Full Text] [Related]
3. Characterization of beta-amyloid peptide precursor processing by the yeast Yap3 and Mkc7 proteases.
Zhang W; Espinoza D; Hines V; Innis M; Mehta P; Miller DL
Biochim Biophys Acta; 1997 Nov; 1359(2):110-22. PubMed ID: 9409808
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network.
Skovronsky DM; Moore DB; Milla ME; Doms RW; Lee VM
J Biol Chem; 2000 Jan; 275(4):2568-75. PubMed ID: 10644715
[TBL] [Abstract][Full Text] [Related]
5. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.
Vassar R; Bennett BD; Babu-Khan S; Kahn S; Mendiaz EA; Denis P; Teplow DB; Ross S; Amarante P; Loeloff R; Luo Y; Fisher S; Fuller J; Edenson S; Lile J; Jarosinski MA; Biere AL; Curran E; Burgess T; Louis JC; Collins F; Treanor J; Rogers G; Citron M
Science; 1999 Oct; 286(5440):735-41. PubMed ID: 10531052
[TBL] [Abstract][Full Text] [Related]
6. A portrait of Alzheimer secretases--new features and familiar faces.
Esler WP; Wolfe MS
Science; 2001 Aug; 293(5534):1449-54. PubMed ID: 11520976
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
8. Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease.
Wolfe MS; Xia W; Moore CL; Leatherwood DD; Ostaszewski B; Rahmati T; Donkor IO; Selkoe DJ
Biochemistry; 1999 Apr; 38(15):4720-7. PubMed ID: 10200159
[TBL] [Abstract][Full Text] [Related]
9. A new wrestler in the battle between alpha- and beta-secretases for cleavage of APP.
Neve RL
Trends Neurosci; 2003 Sep; 26(9):461-3. PubMed ID: 12948653
[TBL] [Abstract][Full Text] [Related]
10. Intracellular domain generation of amyloid precursor protein by epsilon-cleavage depends on C-terminal fragment by alpha-secretase cleavage.
Kume H; Maruyama K; Kametani F
Int J Mol Med; 2004 Jan; 13(1):121-5. PubMed ID: 14654982
[TBL] [Abstract][Full Text] [Related]
11. Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and γ-secretase.
Hogl S; Kuhn PH; Colombo A; Lichtenthaler SF
PLoS One; 2011; 6(6):e21337. PubMed ID: 21695060
[TBL] [Abstract][Full Text] [Related]
12. The non-amyloidogenic pathway: structure and function of alpha-secretases.
Kojro E; Fahrenholz F
Subcell Biochem; 2005; 38():105-27. PubMed ID: 15709475
[TBL] [Abstract][Full Text] [Related]
13. BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.
Marks N; Berg MJ
Neurochem Res; 2010 Feb; 35(2):181-210. PubMed ID: 19760173
[TBL] [Abstract][Full Text] [Related]
14. An empirical model of gamma-secretase activity.
Murphy MP; Wang R; Fraser PE; Fauq A; Golde TE
Ann N Y Acad Sci; 2000; 920():233-40. PubMed ID: 11193156
[TBL] [Abstract][Full Text] [Related]
15. gamma-Secretase inhibitors as molecular probes of presenilin function.
Wolfe MS
J Mol Neurosci; 2001 Oct; 17(2):199-204. PubMed ID: 11816793
[TBL] [Abstract][Full Text] [Related]
16. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.
Yan R; Bienkowski MJ; Shuck ME; Miao H; Tory MC; Pauley AM; Brashier JR; Stratman NC; Mathews WR; Buhl AE; Carter DB; Tomasselli AG; Parodi LA; Heinrikson RL; Gurney ME
Nature; 1999 Dec; 402(6761):533-7. PubMed ID: 10591213
[TBL] [Abstract][Full Text] [Related]
17. Uncovering gamma-secretase.
Steiner H
Curr Alzheimer Res; 2004 Aug; 1(3):175-81. PubMed ID: 15975065
[TBL] [Abstract][Full Text] [Related]
18. Secretases as therapeutic targets for the treatment of Alzheimer's disease.
Dominguez DI; De Strooper B; Annaert W
Amyloid; 2001 Jun; 8(2):124-42. PubMed ID: 11409035
[TBL] [Abstract][Full Text] [Related]
19. L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity.
Shearman MS; Beher D; Clarke EE; Lewis HD; Harrison T; Hunt P; Nadin A; Smith AL; Stevenson G; Castro JL
Biochemistry; 2000 Aug; 39(30):8698-704. PubMed ID: 10913280
[TBL] [Abstract][Full Text] [Related]
20. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
Vassar R
J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]